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PATIENT-RATED OSTEOARTHRITIS SEVERITY IN AN EMPLOYED
POPULATION: COMPARISON OF IMPACT WITH NON-OSTEOARTHRITIS
WORKERS USING DATA FROM THE NATIONAL HEALTH AND
WELLNESS SURVEY
M. DiBonaventura1, S. Gupta1, M. McDonald2, A. Sadosky2, D. Pettitt2,
S. Silverman3. 1Kantar Hlth., New York, NY, USA; 2Pﬁzer, Inc., New York,
NY, USA; 3Cedars-Sinai/UCLA, Los Angeles, CA, USA
Purpose: There is increasing recognition that osteoarthritis (OA) affects
participants in the workforce, but there are only limited data on the
contribution of disease severity to the OA burden in an employed
population. This study evaluated the relationship between patient-
rated OA severity and quality of life, healthcare resource utilization,
productivity, and costs among workers relative to workers without OA.
Methods: Data were analyzed from the 2009 National Health and
Wellness Survey. Univariate and multivariable analyses characterized
employed individuals (full-time, part-time, or self-employed) ≥20 years
of age who were diagnosed with OA and self-rated their OA severity
as mild, moderate, and severe relative to employed individuals
not experiencing OA. Assessments included work productivity (Work
Productivity and Activity Impairment questionnaire [WPAI]); quality of
life (SF-12v2 Health Survey and SF-6D health index); and healthcare
utilization (type and number of resources within the past 6 months).
Direct and indirect costs were also estimated.
Results: 4,876 workers reported being diagnosed with OA (45.0% mild,
45.9% moderate, and 9.1% severe) and 34,896 workers served as the no-
OA comparator cohort. Weighted univariate analysis of demographic
characteristics showed a greater proportion of females in the OA
cohort (53.9% vs 45.6%; P < 0.0001) and higher proportions of OA
individuals in the 40 to 64 year and ≥65 year age ranges (P < 0.0001).
As OA severity increased, workers reported more frequent pain, poorer
quality of life, greater use of speciﬁc healthcare resources (emergency
room and hospitalizations) and reduced productivity, primarily due to
presenteeism. All outcomes indicated a signiﬁcantly greater burden
among workers with OA relative to those without OA (P< 0.0001), and
the disparity between workers with OA and without OA increased at
greater levels of OA severity. Estimated total annual costs per worker
were $9,801 for mild OA, $14,761 for moderate OA, and $22,111 for
severe OA compared with $7,901 for workers without OA (P < 0.0001).
Costs were driven by indirect costs resulting from lost productivity,
accounting for 70% to 74% of total costs, even among workers without
OA.
Conclusions: OA conveys a substantial burden on workers relative to
workers without OA, and this burden increases as self-rated OA severity
increases.
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THE EFFECT OF KNEE BRACES ON QUADRICEPS STRENGTH AND
INHIBITION IN SUBJECTS WITH PATELLOFEMORAL OSTEOARTHRITIS
(PFOA)
M.J. Callaghan, M. Parkes, L.M. Forsythe, L.E. Heathers, D.T. Felson. Univ.
of Manchester, Manchester, United Kingdom
Purpose: Patellar bracing has been adopted for the treatment of non
arthritic patellofemoral pain but has been not been used as readily for
patellofemoral osteoarthritis (PFOA).
One reason for this reluctance may be the perception among
clinicians that prolonged knee or patellar bracing produces quadriceps
weakness.There is little, if any, evidence to support a detrimental effect
on the quadriceps muscle of patellar braces in PFOA.
Therefore, we sought to investigate the immediate and short term
(12 weeks) use of a patellofemoral brace on quadriceps maximum
voluntary contraction (MVC) and arthrogenous muscle inhibition (AMI)
of the quadriceps in patients with PFOA.
Methods: Subjects between ages 40 and 70 with knee pain on stair
climbing, kneeling, prolonged sitting or squatting were included if they
had a K-L score grade 2 or 3 in the PFJ and this was greater than K-L
score for the tibiofemoral compartments. In addition, subjects had to
have lateral or medial patellar facet tenderness or a positive patellar
compression test. Pain was present daily for the at least 3 months with
a score of 4 on a 0–10 cm VAS for a nominated activity.
34 subjects met these criteria (mean age 56.9 years (SD 6.5);
20 females).
AMI data were collected using the twitch interpolation technique. The
maximal single peak torque value with a 1Hz twitch interpolation and
also the activation deﬁcit (AD) levels at 100% MVC were calculated as a
percentage ﬁgure from the ratio: AD = Interpolated twitch torque/Resting
twitch torque (ITT/RTT)×100.
MVC was measured on a dynamometer (Isocom, Isokinetic Technology,
Bingham Industrial Estate, Nottingham, UK). Each subject performed the
task with 90° hip and knee ﬂexion. The knee joint articulation axis was
aligned to the dynamometer mechanic arm lever axis. The length of the
dynamometer arm was adapted according to the length of the leg of the
patient. Standardised verbal encouragement was given during the test
performance.
Treatment: Subjects were given a Bioskin Patellar Tracking Q Brace (Ossur
UK, Manchester, England) as part of a crossover study (brace/no brace) to
look at the effect of bracing on PFOA, which was worn for at least 5 hours
daily for 12 weeks. The order of brace wearing was randomised.
Statistical Analysis: Three separate analyses were performed: Part A
compared brace wearers (n = 17) to non-wearers (n = 17) in terms of
changes in MVC and AMI at six week follow up. Part B examined the
immediate change in MVC and AMI at week 6 of treatment when a
brace was applied in all 34 participants. Finally, part C established
whether MVC and AMI changed at 12 weeks of brace wearing, compared
to baseline. In all analyses, statistics were tested through comparison
of 95% conﬁdence intervals constructed around the median value and
differences were tested using a Wilcoxon Rank Sum test
Results:
Part A: At 6 week follow up, the MVC for brace wearers (median change
= 4.70Nm, IQR −6.30 to 18.6) was not signiﬁcantly different from the
non-wearers (median change = 5.70Nm, IQR −3.30 to 23.60) (z = 0.52,
p = 0.61). However, the AMI at week 6 did differ signiﬁcantly between
groups (z = 1.98, p = 0.048). In the brace wearers group, median
difference in AMI was improved slightly from baseline (−3.94pp (IQR
−7.63to 4.48), compared to 1.75pp (IQR −4.96 to 22.39) in the non-
wearers group.
Part B: MVC was signiﬁcantly higher when a brace was worn during
testing (median difference in torque between brace on and brace off
= 7.5Nm (95% CI 1.00 to 13.76). AMI was not signiﬁcantly different
(median difference in AMI between brace on and brace off = −4.15pp,
95% CI −6.72 to 1.02).
Part C: After 12 weeks of brace wearing, neither MVC (median change
from baseline 3.45Nm, 95% CI −7.51 to 13.6) nor AMI (median change
from baseline −4.37pp, 95% CI −14.47 to 1.26) changed signiﬁcantly
compared to baseline at week 12.
Conclusion:We conclude that in contrast to popular perceptions, patellar
bracing does not notably decrease quadriceps function after 12 weeks
of treatment. In addition, patellar bracing has the instantaneous effect
of signiﬁcantly improving quadriceps MVC. Brace use should not be
discouraged because of concerns about deleterious effects on quadriceps
strength and muscle inhibition.
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IDENTIFICATION OF CLINICAL PHENOTYPES IN KNEE
OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE
J. Knoop1, M. van der Leeden2, C. Thorstensson3, L. Roorda1, W.F. Lems2,
D. Knol2, M. Steultjens4, J. Dekker2. 1Reade (Rheumatology and
Rehabilitation), Amsterdam, Netherlands; 2VU Univ. Med. Ctr., Amsterdam,
Netherlands; 3Spenshult Hosp., Halmstead, Sweden; 4Glasgow Caledonian
Univ., Glasgow, United Kingdom
Purpose: It has been hypothesized that the heterogeneous population of
knee OA patients actually consists of different subgroups or phenotypes.
This study aimed 1) to identify phenotypes of knee OA patients based
on similarities on clinically relevant patient characteristics, and 2) to
compare clinical outcomes of these phenotypes.
Methods: Data from 841 knee OA patients of the Osteoarthritis Initiative
were used. A cluster analysis was performed, in which phenotypes
were identiﬁed based on similarities on four clinically relevant patient
characteristics: severity of radiographic OA, muscle strength, body mass
index and depression. Univariable and multivariable regression analyses
